PURPOSE: Curcumin is an ideal chemopreventive and antitumor agent characterized by poor bioavailability and low stability. The development of synthetic structural analogues like dimethoxycurcumin (DMC) could overcome these drawbacks. In this study we compared the cytotoxicity, metabolism and the epigenetic changes induced by both drugs in leukemia cells. METHODS: Apoptosis and cell cycle analysis were analyzed by flow cytometry. Real-time PCR was used for gene expression analysis. DNA methylation was analyzed by DNA pyrosequencing. The metabolic stability was determined using human pooled liver microsomes. Chromatin Immunoprecipitation was used to quantify histone methylation. RESULTS: Clinically relevant concentration of curcumin and DMC were not cytotoxic to leukemia cells and induced G2/M cell cycle arrest. DMC was more metabolically stable than curcumin. Curcumin and DMC were devoid of DNA hypomethylating activity. DMC induced the expression of promoter methylated genes without reversing DNA methylation and increased H3K36me3 mark near the promoter region of hypermethylated genes. CONCLUSION: DMC is a more stable analogue of curcumin that can induce epigenetic changes not induced by curcumin. DMC induced the expression of promoter methylated genes. The combination of DMC with DNA methyltransferase inhibitors could harness their combined induced epigenetic changes for optimal re-expression of epigenetically silenced genes.
PURPOSE:Curcumin is an ideal chemopreventive and antitumor agent characterized by poor bioavailability and low stability. The development of synthetic structural analogues like dimethoxycurcumin (DMC) could overcome these drawbacks. In this study we compared the cytotoxicity, metabolism and the epigenetic changes induced by both drugs in leukemia cells. METHODS: Apoptosis and cell cycle analysis were analyzed by flow cytometry. Real-time PCR was used for gene expression analysis. DNA methylation was analyzed by DNA pyrosequencing. The metabolic stability was determined using human pooled liver microsomes. Chromatin Immunoprecipitation was used to quantify histone methylation. RESULTS: Clinically relevant concentration of curcumin and DMC were not cytotoxic to leukemia cells and induced G2/M cell cycle arrest. DMC was more metabolically stable than curcumin. Curcumin and DMC were devoid of DNA hypomethylating activity. DMC induced the expression of promoter methylated genes without reversing DNA methylation and increased H3K36me3 mark near the promoter region of hypermethylated genes. CONCLUSION:DMC is a more stable analogue of curcumin that can induce epigenetic changes not induced by curcumin. DMC induced the expression of promoter methylated genes. The combination of DMC with DNA methyltransferase inhibitors could harness their combined induced epigenetic changes for optimal re-expression of epigenetically silenced genes.
Authors: X Yang; A T Ferguson; S J Nass; D L Phillips; K A Butash; S M Wang; J G Herman; N E Davidson Journal: Cancer Res Date: 2000-12-15 Impact factor: 12.701
Authors: Zhongfa Liu; Zhiliang Xie; William Jones; Ryan E Pavlovicz; Shujun Liu; Jianhua Yu; Pui-kai Li; Jiayuh Lin; Jame R Fuchs; Guido Marcucci; Chenglong Li; Kenneth K Chan Journal: Bioorg Med Chem Lett Date: 2008-12-14 Impact factor: 2.823
Authors: Tamer E Fandy; James G Herman; Patrick Kerns; Anchalee Jiemjit; Elizabeth A Sugar; Si-Ho Choi; Allen S Yang; Timothy Aucott; Tianna Dauses; Rosalie Odchimar-Reissig; Jonathan Licht; Melanie J McConnell; Chris Nasrallah; Marianne K H Kim; Weijia Zhang; Yezou Sun; Anthony Murgo; Igor Espinoza-Delgado; Katharine Oteiza; Ibitayo Owoeye; Lewis R Silverman; Steven D Gore; Hetty E Carraway Journal: Blood Date: 2009-06-22 Impact factor: 22.113
Authors: Kevin Pruitt; Rebekah L Zinn; Joyce E Ohm; Kelly M McGarvey; Sung-Hae L Kang; D Neil Watkins; James G Herman; Stephen B Baylin Journal: PLoS Genet Date: 2006-03-31 Impact factor: 5.917
Authors: Hazem E Hassan; Jean-Arnaud Keita; Lawrence Narayan; Sean M Brady; Richard Frederick; Samuel Carlson; Karen C Glass; Senthil Natesan; Thomm Buttolph; Tamer E Fandy Journal: Epigenetics Date: 2016-11-01 Impact factor: 4.528
Authors: Hetty E Carraway; Sridhar A Malkaram; Yana Cen; Aymen Shatnawi; Jun Fan; Hamdy E A Ali; Zakaria Y Abd Elmageed; Thomm Buttolph; James Denvir; Donald A Primerano; Tamer E Fandy Journal: Sci Rep Date: 2020-06-25 Impact factor: 4.379